---
$id: https://graph.org.ai/products/commodity/51334412
$type: Product
source: UNSPSC
code: "51334412"
title: "Pinoxepin"
class: "51334400"
classTitle: "Antipsychotics, synthesized"
family: "51330000"
familyTitle: "Antipsychotics"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Pinoxepin

**UNSPSC Code**: 51334412
**Class**: [Antipsychotics, synthesized](Antipsychotics, synthesized.mdx)
**Family**: [Antipsychotics](../Antipsychotics.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a dopamine antagonist, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Y3YKO9X8N8. European Medicines Agency schedules Pinoxepin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09856MIG. Pinoxepin generally arises in the molecular formula C23H27CLN2O2. The term PINOXEPIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 22, no. 10, 1968, list 8.) PINOXEPIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule pinoxepin under HS 29349990 and SITC 51579. As of Q4 2014, PINOXEPIN remains the US FDA Preferred Term for this commodity. Pinoxepin bears US NLM identifiers UMLS ID C2827300 and NCI Concept Code C84062. SMILES: CLC1CC2C(=C\CCN3CCN(CC3)CCO)/C3C(COC2CC1)CCCC3.

